安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Higher Daily Buprenorphine Doses Help Manage OUD - Medscape
Higher daily buprenorphine doses may help patients better manage opioid use disorder (OUD), data from a National Institutes of Health (NIH) study suggested The new data highlight that the dose
- Buprenorphine Prescribing via Telehealth Delayed - Medscape
The rules — “Expansion of Buprenorphine Treatment via Telemedicine Encounter” and “Continuity of Care via Telemedicine for Veterans Affairs Patients” — were initially proposed in March
- Buprenorphine for Chronic Pain: How to Prescribe It - Medscape
Chan: Buprenorphine is a partial opioid agonist that has high affinity for the mu opiate receptor It has a ceiling effect on respiratory depression and typically fewer side effects than full
- Low-Dose Buprenorphine Falls Short for Fentanyl Users - Medscape
Outpatient low-dose initiation (LDI) of buprenorphine has a low rate of success in people with opioid use disorder (OUD) using fentanyl, with a completion rate of just 34% and retention rates of
- Despite X-Waiver Elimination, Buprenorphine Rx Decline - Medscape
Doses of buprenorphine prescriptions dispensed totalled 150,969,086 in 2020 and 155,751,403 in 2021, accounting for a 3 2% increase Nebraska (+83 8%), South Dakota (+41 1%), and New York (+37 1%
- EMA OKs Sublingual Formulation for Opioid Dependence - Medscape
Buprenorphine Neuraxpharm is a hybrid medicine of Subutex, a formulation of buprenorphine hydrochloride manufactured by Indivior UK Limited and available as 0 4 mg, 2 mg, and 8 mg sublingual
- Treating Opioid Use During Pregnancy Helps Mom and Baby - Medscape
Pregnant women treated with buprenorphine for opioid use disorder (OUD) experienced significantly better outcomes for themselves and their infants than women not treated with buprenorphine during
- Higher Buprenorphine Doses Safe and Effective in Pregnancy - Medscape
Second-trimester buprenorphine initiation at moderate doses was associated with 44% lower odds of postpartum treatment continuation than consistent usage at high doses (aOR, 0 56; 95% CI, 0 43-0
|
|
|